Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a M4 Positive Allosteric Modulator.
Saudi Railway Company and Ericsson Partner on 5G Technology The Saudi Railway Company (SAR) has signed a memorandum of understanding (MoU)…
Pole-mount Agrivoltaics Project at Puerto Rico Coffee Farm A new agrivoltaics system has been installed at a coffee farm in Adjuntas, Puer…
Rolex 24 Grid Expansion Not Possible Due to Pit Lane Space IMSA President John Doonan stated that expanding the Rolex 24 grid is currently…
ASX Market Update The Australian stock market is experiencing a decline, led by significant losses in the healthcare and tech sectors, des…
Designing Light-Filled Living Spaces: How Lifestyle Remodeling Is Shaping the Future of Tampa Sunrooms In Florida, natural light is one of…
A Studio With a Heated Solarium on West 14th for $780,000 For under a million dollars, various housing configurations are available, inclu…
Abbott Directed to Provide Prescribing Details for Triamcinolone Hexacetonide Pre-Filled Syringe The Subject Expert Committee (SEC) under …
Councils' Role in New Towns Success Peers have emphasized the importance of councils in making the New Towns programme a success. A…
Prairie Portraits: Alex Rapp The Prairie Portraits series features founders, funders and community builders from Nebraska's innovation and…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…